Invited review: An evaluation of the likely effects of individualized feeding of concentrate supplements to pasture-based dairy cows.

In pasture-based dairy systems, supplementary feeds are used to increase dry matter intake and milk production. Historically, supplementation involved the provision of the same amount of feed (usually a grain-based concentrate feed) to each cow in the herd during milking (i.e., flat-rate feeding). The increasing availability of computerized feeding and milk monitoring technology in milking parlors, however, has led to increased interest in the potential benefits of feeding individual cows (i.e., individualized or differential feeding) different amounts and types of supplements according to one or more parameters (e.g., breeding value for milk yield, current milk yield, days in milk, body condition score, reproduction status, parity). In this review, we consider the likely benefits of individualized supplementary feeding strategies for pasture-based dairy cows fed supplements in the bail during milking. A unique feature of our review compared with earlier publications is the focus on individualized feeding strategies under practical grazing management. Previous reviews focused primarily on research undertaken in situations where cows were offered ad libitum forage, whereas we consider the likely benefits of individualized supplementary feeding strategies under rotational grazing management, wherein pasture is often restricted to all or part of a herd. The review provides compelling evidence that between-cow differences in response to concentrate supplements support the concept of individualized supplementary feeding.

Compound heterozygous female with fragile X syndrome.

We report on a 15-year-old compound heterozygous young woman with fragile X syndrome who has a full mutation of 363 repeats on one X chromosome and a premutation of 103 repeats on the other X chromosome. As predicted, subsequent testing demonstrated that her father carries a premutation (98 repeats) as does her mother (146 repeats). There is only one previous report of a compound heterozygous female with fragile X syndrome. By quantitation of Southern blot signals, the activation ratio for the premutation (the proportion of the premutation on the active X chromosome) was determined to be 0.78. Immunocytochemistry of blood smears showed fragile X mental retardation-1 protein (FMRP) expression in 63.5% of lymphocytes. Cognitively, this woman is functioning in the mid-range of involvement for fragile X females. She attends regular classes and receives supplemental assistance for her learning disabilities. She experiences behavior characteristics typical of females with fragile X syndrome including severe shyness, anxiety, panic episodes, mood swings, and attention deficits. She has responded very well to appropriate treatment including fluoxetine for anxiety, methylphenidate for attentional problems, and educational therapy.